Fundz

Amide Technologies, Inc. reported raising $2 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATENov 27, 2017

Amount Raised

$2 Million

$2 Million sold, per SEC Form D (first sale Nov 27, 2017)

Round Type

Seed

CambridgeManufacturingBiotechnology

Quick answer

Amide Technologies raised $2 Million in a Seed round, dated November 27, 2017. Amide Technologies is based in Cambridge, Massachusetts, United States.

How much did Amide Technologies raise?
Amide Technologies raised $2 Million in a Seed round on November 27, 2017.
What does Amide Technologies do?
Amide Technologies is a leading biotech company specializing in the synthesis of complex peptides.
Where is Amide Technologies based and how big is it?
Amide Technologies is based in Cambridge, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Amide Technologies that raised within 45 days of this round, from Fundz verified event records.

  • Vioguard raised $1M (Seed) on January 5, 2018.
  • Tmunity Therapeutics, Inc. raised $5M (Seed) on January 3, 2018.
  • InspireMD raised $750K on December 12, 2017.
  • Nature's Toolbox raised $372K (Seed) on December 6, 2017.
  • Space Tango, Inc. raised $150K (Seed) on November 20, 2017.
  • Nusano raised $2.4M (Seed) on November 6, 2017.

Who to call at Amide Technologies, and when

A new round usually means Amide Technologies is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Amide Technologies raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Amide Technologies, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Amide Technologies. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Amide Technologies

Location

Cambridge, Massachusetts, United States

About

Amide Technologies is a leading biotech company specializing in the synthesis of complex peptides. The company is at the intersection of robotics, chemistry, and AI, driving major advancements in peptide manufacturing. Amide offers on-demand complex peptide manufacturing at unprecedented speed, empowering scientists at the forefront of peptide drug design.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Amide Technologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Amide Technologies's next move

See what Strategic adds

Amide Technologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.